Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.

Di Pietro A, Conseil G, Pérez-Victoria JM, Dayan G, Baubichon-Cortay H, Trompier D, Steinfels E, Jault JM, de Wet H, Maitrejean M, Comte G, Boumendjel A, Mariotte AM, Dumontet C, McIntosh DB, Goffeau A, Castanys S, Gamarro F, Barron D.

Cell Mol Life Sci. 2002 Feb;59(2):307-22. Review.

PMID:
11915946
2.

P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.

Di Pietro A, Dayan G, Conseil G, Steinfels E, Krell T, Trompier D, Baubichon-Cortay H, Jault J.

Braz J Med Biol Res. 1999 Aug;32(8):925-39. Review.

3.

Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.

Li S, Zhang W, Yin X, Xing S, Xie HQ, Cao Z, Zhao B.

Anticancer Agents Med Chem. 2015;15(4):423-32. Review.

PMID:
25929575
4.

Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

Alvarez AI, Real R, Pérez M, Mendoza G, Prieto JG, Merino G.

J Pharm Sci. 2010 Feb;99(2):598-617. doi: 10.1002/jps.21851. Review.

PMID:
19544374
5.

Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.

Pérez-Victoria JM, Di Pietro A, Barron D, Ravelo AG, Castanys S, Gamarro F.

Curr Drug Targets. 2002 Aug;3(4):311-33. Review.

PMID:
12102602
6.

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

Ahmed-Belkacem A, Pozza A, Macalou S, Pérez-Victoria JM, Boumendjel A, Di Pietro A.

Anticancer Drugs. 2006 Mar;17(3):239-43. Review.

PMID:
16520651
8.

Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily.

Altenberg GA.

Curr Med Chem Anticancer Agents. 2004 Jan;4(1):53-62. Review.

PMID:
14754412
9.

The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

Assaraf YG.

Drug Resist Updat. 2006 Aug-Oct;9(4-5):227-46. Epub 2006 Nov 7. Review.

PMID:
17092765
10.

The role of ABC transporters in clinical practice.

Leonard GD, Fojo T, Bates SE.

Oncologist. 2003;8(5):411-24. Review.

11.

Reversing agents for ATP-binding cassette drug transporters.

Lee CH.

Methods Mol Biol. 2010;596:325-40. doi: 10.1007/978-1-60761-416-6_14. Review.

PMID:
19949930
12.

New light on multidrug binding by an ATP-binding-cassette transporter.

Shilling RA, Venter H, Velamakanni S, Bapna A, Woebking B, Shahi S, van Veen HW.

Trends Pharmacol Sci. 2006 Apr;27(4):195-203. Epub 2006 Mar 20. Review.

PMID:
16545467
13.
14.
15.

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

Pérez-Tomás R.

Curr Med Chem. 2006;13(16):1859-76. Review.

PMID:
16842198
16.

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.

Modok S, Mellor HR, Callaghan R.

Curr Opin Pharmacol. 2006 Aug;6(4):350-4. Epub 2006 May 11. Review.

PMID:
16690355
17.

ABC transporters: unvalidated therapeutic targets in cancer and the CNS.

Robey RW, Massey PR, Amiri-Kordestani L, Bates SE.

Anticancer Agents Med Chem. 2010 Oct 1;10(8):625-33. Review.

18.

Improving cancer chemotherapy with modulators of ABC drug transporters.

Shukla S, Ohnuma S, Ambudkar SV.

Curr Drug Targets. 2011 May;12(5):621-30. Review.

19.

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.

Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J.

Cancer Lett. 2016 Jan 1;370(1):153-64. doi: 10.1016/j.canlet.2015.10.010. Epub 2015 Oct 20. Review.

PMID:
26499806
20.

Non-P-glycoprotein drug export mechanisms of multidrug resistance.

List AF.

Semin Hematol. 1997 Oct;34(4 Suppl 5):20-4. Review.

PMID:
9408957

Supplemental Content

Support Center